Unison Asset Management LLC Buys 1,405 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Unison Asset Management LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 18,291 shares of the healthcare conglomerate’s stock after buying an additional 1,405 shares during the quarter. UnitedHealth Group accounts for approximately 4.5% of Unison Asset Management LLC’s portfolio, making the stock its 9th biggest position. Unison Asset Management LLC’s holdings in UnitedHealth Group were worth $9,253,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in UNH. AMF Tjanstepension AB boosted its holdings in UnitedHealth Group by 88.0% in the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after purchasing an additional 121,180 shares in the last quarter. Hudson Value Partners LLC raised its stake in UnitedHealth Group by 8.3% during the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after acquiring an additional 82 shares in the last quarter. Wealth Group Ltd. boosted its stake in UnitedHealth Group by 4.0% in the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after acquiring an additional 68 shares in the last quarter. Sendero Wealth Management LLC boosted its position in shares of UnitedHealth Group by 1.4% in the 3rd quarter. Sendero Wealth Management LLC now owns 2,692 shares of the healthcare conglomerate’s stock valued at $1,574,000 after purchasing an additional 37 shares during the period. Finally, Tobam lifted its stake in UnitedHealth Group by 22.7% in the third quarter. Tobam now owns 2,320 shares of the healthcare conglomerate’s stock valued at $1,356,000 after buying an additional 429 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 0.6 %

Shares of NYSE UNH opened at $526.68 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market capitalization of $484.69 billion, a PE ratio of 33.98, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The firm’s 50-day moving average is $530.85 and its two-hundred day moving average is $564.52.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the business earned $5.83 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently weighed in on UNH. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Royal Bank of Canada cut their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Finally, Bank of America cut their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.